Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer

2017-07-01
Volkan, Mürvet
Güray, Nülüfer Tülün
Asik, Elif
Lopez-Berestein, Gabriel
Ozpolat, Bulent
Kahraman, Nermin
Citation Formats
M. Volkan, N. T. Güray, E. Asik, G. Lopez-Berestein, B. Ozpolat, and N. Kahraman, “Eucaryotic elongation factor 2kinaze is a novel therapeutic target in BRCA1 mutated breast cancer,” 2017, vol. 77, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/38963.